Oral Estradiol Cost in New Hampshire 2026

What Does Oral Estradiol Cost in New Hampshire Right Now?

The average cash-pay price for oral estradiol tablets at New Hampshire retail pharmacies in 2026 is approximately $15 per month. That figure sits roughly 62% below the $40 per month manufacturer list price for generic formulations. Prices at individual pharmacies vary by up to $10 depending on which chain or independent you use, so calling ahead or using a price-comparison tool before filling makes a measurable difference.

Generic estradiol tablets have been on the U.S. market for decades. Because multiple manufacturers produce them, competition keeps retail prices low even without insurance. The original branded product, Estrace, carries a substantially higher list price, but prescribers almost universally allow generic substitution. Estrace and its generics are FDA-approved for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, as documented on the FDA drug label database [1].

The Women's Health Initiative (WHI), published in JAMA in 2002 (N=16,608), remains the most cited trial on systemic estrogen therapy and shaped prescribing patterns for the past two decades [2]. Subsequent re-analyses, including the WHI follow-up data published in JAMA Internal Medicine, clarified that younger postmenopausal women aged 50 to 59 years showed a more favorable cardiovascular risk profile on oral estrogen than older cohorts [3]. The Menopause Society (formerly NAMS) 2023 position statement affirms that "for most healthy symptomatic women who are younger than 60 years or within 10 years of menopause onset, the benefits of hormone therapy outweigh the risks" [4]. That clinical endorsement underpins the continued demand for oral estradiol across New Hampshire and nationally.

GoodRx, RxSaver, and similar coupon platforms consistently bring the cash price for a 30-tablet supply of estradiol 1 mg to between $9 and $18 at major NH chains, including CVS, Walgreens, Walmart Pharmacy, and Hannaford Pharmacy locations. Applying a savings card at the pharmacy counter takes less than 60 seconds and requires no membership.

Does New Hampshire Medicaid Cover Oral Estradiol?

New Hampshire Medicaid (NH Medicaid) does not currently cover oral estradiol for moderate-to-severe vasomotor symptoms of menopause. This is a notable coverage gap relative to some other state Medicaid programs. Enrollees seeking treatment for menopausal symptoms must either pay cash, pursue a manufacturer savings program, or discuss compounded alternatives with their prescriber.

NH Medicaid does maintain coverage for estrogen-containing products prescribed for specific gynecologic indications outside of menopausal symptom management, such as hypogonadism or premature ovarian insufficiency (POI). Clinicians treating NH Medicaid patients for those diagnoses should document the specific ICD-10 code (E28.39 for primary ovarian failure or E23.0 for hypopituitarism, for example) to support prior-authorization approval. The CDC tracks POI prevalence at approximately 1% of women under age 40 [5], a population for whom estrogen replacement carries strong evidence of long-term bone and cardiovascular benefit [6].

If your income qualifies you for NH Medicaid, speak with your prescriber about whether your specific diagnosis allows for a covered route. Appeals are possible when the clinical record supports a covered indication.

Is Compounded Oral Estradiol Legal in New Hampshire?

Compounded oral estradiol is legal in New Hampshire when prepared by a 503A-licensed compounding pharmacy under a valid patient-specific prescription. The FDA distinguishes 503A pharmacies (patient-specific, state-regulated) from 503B outsourcing facilities (larger-scale, federally registered). New Hampshire Board of Pharmacy oversees 503A compounders operating within the state [7].

503A compounding pharmacies may prepare customized oral estradiol formulations, including doses or combinations not available commercially. Common examples include combined estradiol and progesterone capsules or lower-dose formulations such as 0.25 mg tablets for patients who are sensitive to standard 0.5 mg or 1 mg doses.

From a regulatory standpoint, compounded estradiol is not FDA-approved in the same sense as commercially manufactured tablets. The FDA guidance on compounding clarifies that compounded products lack the standardized bioequivalence testing required for approved generics [8]. That does not make them illegal or unsafe when prepared by a licensed pharmacy under a physician's prescription, but prescribers should document the clinical rationale for choosing a compounded formulation over a commercially available alternative.

Cost for compounded oral estradiol through certain telehealth-partnered 503A pharmacies in New Hampshire can reach $0 per month when a telehealth platform absorbs the pharmacy cost as part of a subscription model. Patients should verify this directly with the prescribing platform. Compounded formulations are never covered by insurance or Medicaid.

Which Insurance Plans Cover Oral Estradiol in New Hampshire?

Coverage depends on the insurer, the specific plan tier, and whether a prior authorization is required. The Affordable Care Act (ACA) does not mandate coverage for hormone therapy used for menopausal symptoms across all plan types, so coverage varies widely.

Commercial Plans. Most commercial insurance plans offered through NH employers or the NH HealthRx marketplace (healthcare.gov) place generic estradiol tablets on Tier 1 or Tier 2 of the formulary. A Tier 1 generic typically costs $0 to $15 per fill with a standard copay; Tier 2 lands between $15 and $45. The USPSTF does not recommend routine screening HRT for chronic disease prevention in postmenopausal women [9], but that guideline position does not affect formulary placement for symptom-directed prescribing.

Medicare Part D. Medicare Part D plans may cover oral estradiol depending on the plan's formulary. CMS data show that most benchmark Part D plans include at least one estradiol formulation on a low-cost tier. Patients should compare Part D plans annually during open enrollment (October 15 through December 7) using the Medicare Plan Finder tool. The FDA-approved indication matters here: plans are more likely to cover tablets prescribed for vasomotor symptoms than for off-label uses [10].

ACA Marketplace Plans. NH marketplace plans through Anthem, Harvard Pilgrim, and Ambetter (carriers active in NH as of 2025) each cover generic estradiol on their base formularies, though cost-sharing varies. A silver-tier plan enrollee might pay $5 to $20 per month depending on deductible status.

Self-Funded Employer Plans. Self-funded plans are governed by ERISA, not state insurance law. NH's state insurance mandates do not apply. Coverage terms are set by the employer. Reviewing the Summary of Benefits and Coverage (SBC) document or contacting the plan's pharmacy benefit manager directly is the only reliable way to confirm coverage.

What Is the Cheapest Way to Get Oral Estradiol in New Hampshire?

For most cash-pay patients, applying a GoodRx, RxSaver, or NeedyMeds coupon at a high-volume retailer produces the lowest price. Walmart Pharmacy and Costco Pharmacy consistently rank among the cheapest for generic estradiol in NH, with prices observed as low as $9 for a 30-day supply of estradiol 1 mg tablets when a coupon is applied.

The step-by-step approach to minimize cost:

1. Ask your prescriber to write for generic estradiol tablets (not Estrace) with substitution permitted.
2. Look up the current coupon price at your preferred NH pharmacy on GoodRx or RxSaver before going in.
3. Present the coupon at the pharmacy counter. You cannot combine a coupon with insurance on the same fill; choose whichever is cheaper.
4. If your plan covers estradiol, run a test claim through insurance first, then compare that cost to the coupon price.

Manufacturer assistance programs for branded Estrace exist but are structured for patients with private insurance who have high copays, not for Medicaid enrollees or cash-pay patients below a certain income threshold. Pfizer and Allergan (the current Estrace rights holder after multiple acquisitions) maintain patient assistance programs; income eligibility typically falls at or below 400% of the federal poverty level [11].

Telehealth Prescribing of Oral Estradiol in New Hampshire

Telehealth prescribing of oral estradiol is fully legal in New Hampshire. NH adopted permanent telehealth parity laws following pandemic-era expansions, allowing licensed NH clinicians to prescribe Schedule III and non-scheduled medications including estradiol via synchronous audio-video visits and, in some cases, asynchronous (store-and-forward) consultation [12].

Patients do not need an in-person pelvic exam before receiving a prescription for oral estradiol for vasomotor symptoms in most clinical contexts. The Menopause Society and the American College of Obstetricians and Gynecologists (ACOG) both support individualized symptom-based assessment, which is feasible via telehealth [13]. ACOG's 2022 committee opinion on telehealth states that "virtual care can maintain or improve access to reproductive health services when delivered appropriately" [14].

A telehealth visit for oral estradiol in NH typically costs $25 to $99 for a first visit through platforms that specialize in menopause care or hormone therapy. Some platforms bundle the monthly medication cost with the visit fee. When comparing platforms, confirm whether the pharmacy is 503A-licensed in NH, whether the clinician is NH-licensed, and whether labs (a baseline estradiol level or lipid panel) are required before the first prescription is issued.

How Estradiol Dosing Affects Monthly Cost

Dose directly affects cost. Generic estradiol tablets are commercially available in 0.5 mg, 1 mg, and 2 mg strengths. Most pharmacies price all three strengths at roughly the same per-tablet cost, so a patient taking 2 mg daily does not necessarily pay more than one taking 0.5 mg.

Standard dosing for moderate-to-severe vasomotor symptoms starts at 1 mg per day. The REPLENISH trial (N=1,835) evaluated combined estradiol/progesterone capsules (TX-001HR) and found the 1 mg estradiol/100 mg progesterone dose reduced moderate-to-severe vasomotor symptoms by 74% over 12 weeks compared to 47% for placebo [15]. That trial used an oral combination capsule, not plain estradiol tablets, but the estradiol dose range is directly comparable. The FDA-approved dosing range for oral estradiol monotherapy spans 0.5 mg to 2 mg daily, with the lowest effective dose recommended by current guidelines [4].

Patients using unopposed estradiol (without a progestogen) typically have had a surgical hysterectomy. Those with an intact uterus require concurrent progestogen therapy to prevent endometrial hyperplasia. The PEPI Trial (N=875) demonstrated that unopposed estrogen significantly increased the rate of adenomatous or atypical endometrial hyperplasia versus estrogen-progestogen combinations (34.3% vs. 1.0% at three years) [16]. Adding micronized progesterone 200 mg daily for 12 days per month or 100 mg daily continuously adds roughly $20 to $40 per month in additional cash-pay costs.

New Hampshire-Specific Discount Programs and Resources

Several national and state-adjacent programs help NH residents reduce out-of-pocket costs for oral estradiol.

NeedyMeds. NeedyMeds maintains a database of patient assistance programs for estradiol products. NH residents can search by zip code at needymeds.org [17].

RxAssist. RxAssist compiles pharmaceutical company patient assistance programs and income-eligibility criteria. Most programs require income documentation and a prescriber signature [18].

NH DHHS Prescription Drug Affordability Programs. The New Hampshire Department of Health and Human Services maintains a prescription drug assistance referral service for uninsured and underinsured residents. While this program does not directly fund estradiol, case managers can connect patients with qualifying manufacturer assistance programs.

340B-Eligible Clinics. Federally Qualified Health Centers (FQHCs) and certain rural health clinics in NH participate in the 340B Drug Pricing Program, which requires drug manufacturers to sell covered outpatient drugs at a significant discount to eligible providers [19]. Patients receiving care at a 340B-covered NH clinic may pay dramatically less, sometimes $0, for a prescription filled through the clinic's in-house or contract pharmacy. NH FQHCs include Greater Nashua Mental Health (which offers integrated primary care), Families First Health and Support Center in Portsmouth, and Ammonoosuc Community Health Services in Littleton.

Clinical Safety Context: What Patients and Prescribers Should Know

Oral estradiol is a hepatically metabolized form of systemic estrogen. First-pass liver metabolism converts oral estradiol to estrone at higher ratios than transdermal delivery, producing higher circulating estrone-to-estradiol ratios. This metabolic distinction is clinically meaningful for patients with elevated baseline triglycerides. A 2007 observational study published in Arteriosclerosis, Thrombosis, and Vascular Biology (N=3,189) found that oral but not transdermal estrogen was associated with a modest increase in venous thromboembolism (VTE) risk, with an adjusted odds ratio of 3.5 for oral versus 0.9 for transdermal in women aged 45 to 70 [20].

The WHI (2002) oral conjugated equine estrogen (CEE) arm reported a VTE hazard ratio of 2.13 (95% CI 1.39 to 3.25) versus placebo in the estrogen-plus-progestin group [2]. This figure is widely cited but applies to CEE with medroxyprogesterone acetate, not to oral estradiol with micronized progesterone, which appears to carry a more favorable risk profile based on the E3N cohort study (N=80,377) published in Circulation [21].

The FDA-approved label for oral estradiol tablets carries a boxed warning for endometrial cancer (in unopposed estrogen use), cardiovascular disease, probable dementia, and breast cancer, based largely on WHI data [1]. Prescribers using the lowest effective dose for the shortest appropriate duration remain consistent with FDA label guidance and Menopause Society recommendations [4].

Baseline labs before initiating oral estradiol typically include fasting lipids, fasting glucose, blood pressure, and a clinical breast examination or mammogram per age-appropriate screening guidelines. The American Cancer Society recommends annual mammograms starting at age 45 for average-risk women [22].

Comparing Oral Estradiol to Other Estrogen Delivery Routes in NH

Transdermal estradiol patches (Vivelle-Dot, Minivelle, generics) are available in NH at cash-pay prices ranging from $20 to $60 per month depending on the dose and pharmacy. Estradiol gel (Divigel, EstroGel) and spray (Evamist) carry higher list prices, typically $80 to $150 monthly, with limited generic competition. Vaginal estradiol rings (Estring, Femring) cost $100 to $300 quarterly.

For purely systemic symptom relief, oral tablets are the lowest-cost option for most NH cash-pay patients in 2026. The Endocrine Society's 2015 clinical practice guideline on postmenopausal hormone therapy states that "the route of administration should be selected based on patient preference, medical history, and the specific clinical indication" [23]. Route selection is not purely a cost decision, but cost is a legitimate factor in shared decision-making.

Practical Steps for NH Residents Starting Oral Estradiol in 2026

1. Confirm NH licensure of your telehealth or in-person prescriber before the visit.
2. Request generic estradiol tablets with DAW-0 (dispense as written waived), allowing the pharmacist to choose the lowest-cost generic.
3. Run a GoodRx price check for the specific dose at your nearest NH pharmacy before leaving the visit.
4. If you have NH Medicaid, ask your prescriber whether your diagnosis supports a covered indication (hypogonadism, POI) rather than menopausal symptoms.
5. Ask about 340B-affiliated clinics in your county if cost remains a barrier.
6. If a compounded formulation is proposed, verify the compounding pharmacy holds a current NH 503A license via the NH Board of Pharmacy license-verification portal.

A baseline fasting lipid panel is recommended before starting oral estradiol in any patient with a personal or family history of hypertriglyceridemia, given the hepatic estrone load of oral delivery. Recheck triglycerides at the 3-month follow-up visit.